ArticleCancer biology & medicine2018

G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future.

Angel Mauricio Castro-Gamero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.